AI-Driven Breakthroughs: FDA Clearances and Major Partnerships - Life AI Weekly #70
June 03, 2026 -
Life AI Weekly
Hi there,
Welcome to this week's edition of Life AI Weekly, where we delve into the latest advancements in AI within the healthcare and life sciences sectors. This week, we're highlighting a variety of groundbreaking developments, from AI-assisted medical procedures to strategic partnerships aimed at enhancing healthcare delivery. In China, a study published in the Annals of Family Medicine shows promising results for AI-assisted ultrasound in detecting carotid artery plaque, potentially paving the way for broader applications with further research and training.
Meanwhile, Biohaven has shared positive outcomes from its Phase 1b study on AI-driven protein degraders for treating conditions like Graves' disease and IgA nephropathy. Additionally, Subtle Medical has received FDA clearance for its AI-powered SubtleHD™(PET) software, which promises to improve PET imaging quality and streamline workflows. These stories, among others, underscore the transformative impact of AI technologies in advancing healthcare solutions and improving patient outcomes.
Welcome to this week's edition of Life AI Weekly, where we delve into the latest advancements in AI within the healthcare and life sciences sectors. This week, we're highlighting a variety of groundbreaking developments, from AI-assisted medical procedures to strategic partnerships aimed at enhancing healthcare delivery. In China, a study published in the Annals of Family Medicine shows promising results for AI-assisted ultrasound in detecting carotid artery plaque, potentially paving the way for broader applications with further research and training.
Meanwhile, Biohaven has shared positive outcomes from its Phase 1b study on AI-driven protein degraders for treating conditions like Graves' disease and IgA nephropathy. Additionally, Subtle Medical has received FDA clearance for its AI-powered SubtleHD™(PET) software, which promises to improve PET imaging quality and streamline workflows. These stories, among others, underscore the transformative impact of AI technologies in advancing healthcare solutions and improving patient outcomes.
AI-Assisted Ultrasound Study in China Shows Promise
A study in Annals of Family Medicine indicates that general practitioners in Shanghai successfully used AI-assisted portable ultrasound to detect carotid artery plaque in high-risk patients, suggesting potential for broader use with further testing and training. Read more
Biohaven's AI-Driven Protein Degraders Show Positive Results
Biohaven has reported positive clinical data from its Phase 1b study on AI-driven protein degraders BHV-1300 and BHV-1400, showing significant reductions in disease markers for Graves' disease and IgA nephropathy. Read more
Subtle Medical's AI Software for PET Imaging Gets FDA Clearance
Subtle Medical has received FDA clearance for its AI-powered SubtleHD™(PET) software, which enhances PET imaging quality and accelerates workflows. This development addresses the increasing global demand for PET scans. Read more
Debut and Natura Partner for AI-Discovered Ingredient
The partnership between Debut and Natura focuses on commercializing an AI-discovered longevity ingredient for beauty products in Latin America, with potential launch by 2027. Read more
Ember LifeSciences Raises $27M in Series A Funding
Ember LifeSciences has secured $27 million in Series A funding with contributions from Amgen Ventures and TDF Ventures to advance its AI-driven cold chain logistics solutions. Read more
L.E.K. Consulting Survey on U.S. Health Systems and AI
A survey by L.E.K. Consulting reveals a financial divide among U.S. health systems, with some investing in AI to improve efficiency despite challenges. Read more
Fresenius Medical Care Highlights AI at ERA Congress 2026
Fresenius Medical Care is presenting its latest research and AI innovations at the European Renal Association Congress 2026, focusing on improving kidney care through advancements in hemodiafiltration and patient outcomes. Read more
VolitionRx Reports 300% Revenue Growth
VolitionRx Limited has reported a significant 300% increase in revenue for Q1 2026, reaching $1 million. The company is also expanding its AI-driven diagnostic opportunities, including advancements in veterinary diagnostics and cancer detection technologies. Read more
Merck KGaA Partners with Veeva Systems for AI in Healthcare
Merck KGaA has announced a partnership with Veeva Systems to enhance AI integration in healthcare operations. The collaboration focuses on improving data connectivity and operational flexibility through Veeva Vault CRM. Read more
FDA Grants Breakthrough Designation to Gene Solutions' Cancer Test
The FDA has awarded Breakthrough Device Designation to Gene Solutions for its SPOT-MAS 10 test, which uses machine learning to detect cancer in asymptomatic adults. Read more
PartsSource Unveils AI Asset Uptime at AAMI eXchange
PartsSource has announced new AI-driven capabilities for its PRO platform at the AAMI eXchange, designed to enhance clinical asset performance and operational readiness in healthcare systems. Read more
Accrete Health Partners Invests in ReveloHealth
Accrete Health Partners has made a strategic investment in ReveloHealth to enhance AI-driven contract performance and reimbursement accuracy in healthcare systems. Read more
Form.io and Contentstack Partner for Data Collection
On May 28, 2026, Form.io and Contentstack announced a partnership to improve compliant data collection for enterprises in regulated sectors like healthcare and finance. Read more
Sirona Medical Partners with Everlight Radiology for Global AI Services
Sirona Medical has partnered with Everlight Radiology to provide AI-powered radiology services to 350 hospitals globally, marking its first international collaboration. Read more
World Health Expo Miami 2026 to Highlight AI in Healthcare
The World Health Expo Miami 2026 will feature global leaders and companies showcasing AI and robotics innovations in healthcare from June 17-19 at the Miami Beach Convention Center. Read more
Cognizant Introduces TriZetto Unify with AI for Healthcare
Cognizant has launched TriZetto Unify, a platform using AI agents to tackle administrative issues in U.S. healthcare, focusing on prior authorization processes. Read more
Holmusk Expands NeuroBlu Platform
Holmusk has expanded its NeuroBlu platform to include data from over 46 million de-identified patients, enhancing AI-driven insights in neurology and behavioral health. Read more
GRAIL's NHS-Galleri Trial Shows 22% Drop in Late-Stage Cancer Diagnoses
The GRAIL NHS-Galleri trial has shown a 22% decrease in stage IV cancer diagnoses using AI, indicating the potential of AI in early cancer detection. Read more
3billion Introduces Genomic Newborn Screening Service
3billion has launched 3B-NEO, a genomic screening service for newborns, analyzing 595 genes to assess genetic risks early. This service is intended for hospitals and pediatric clinics, offering Whole Exome and Whole Genome Sequencing options. Read more
Conscientia Health Unveils AI Platform for Mental Healthcare
Conscientia Health has introduced an AI platform designed to enhance mental healthcare through clinician-driven solutions, focusing on improving patient-provider matching and clinical decision support. Read more
AssureCare Launches AI Nutrition Platform NutraVance
AssureCare has introduced NutraVance™, an AI-enabled platform aimed at integrating nutrition into healthcare workflows to enhance population health management. Read more
Kedrion Biopharma and InstaLILY Host AI Summit
On June 3, 2026, Kedrion Biopharma and InstaLILY will host a summit in New York to discuss AI in healthcare, focusing on patient experiences and decision-making. Read more
Compal and NVIDIA Enhance AI in Smart Hospitals
At COMPUTEX 2026, Compal Electronics and NVIDIA demonstrated their collaboration to improve smart hospital operations with the POLYMEDX platform, integrating AI and robotics. Read more
Genomics Unveils Mystra AI for Drug Discovery
Genomics has launched the Mystra AI platform to enhance drug discovery by utilizing a vast human genetics database. The platform aims to improve the success rate of drug development by providing genetic insights through a conversational interface. Read more
Clarius Mobile Health's AI Gains FDA Approval
The FDA has approved Clarius Mobile Health's Ejection Fraction AI, which automates the calculation of left ventricular ejection fraction in cardiac ultrasound assessments, aiming to enhance diagnostic accuracy and speed. Read more
Mount Sinai Partners with Clarium for AI in Surgical Supply Management
The Mount Sinai Health System has teamed up with Clarium to use AI-driven computer vision technology to enhance surgical supply management, aiming to improve data accuracy and reduce waste. Read more
Invizix Finalist in ADA 2026 Innovation Challenge
Invizix, previously known as Geminii Health, has been named a finalist in the American Diabetes Association's 2026 Innovation Challenge. The company will showcase its AI-driven diabetes management platform at the ADA's 86th Scientific Sessions in New Orleans. Read more
Acclinate and HCN Global Partner for AI-Driven Clinical Research
The partnership between Acclinate and HCN Global seeks to improve clinical research access for underrepresented Hispanic and Latino communities through enhanced engagement and participation in trials. Read more
Mayo Clinic and Microsoft Partner on AI Model for Healthcare
The Mayo Clinic and Microsoft have announced a collaboration to develop an AI model aimed at improving healthcare delivery. The project will leverage Mayo Clinic's clinical data and Microsoft's AI technology to enhance patient care and clinical decision-making. Read more
American Diabetes Association Invests in UpDoc for AI Solutions
The American Diabetes Association has invested in UpDoc to enhance chronic disease management using AI. This initiative aims to improve diabetes care for millions of Americans with AI-driven patient support. Read more
WeInfuse and Trial IQ Partner for AI in Clinical Research
On June 2, 2026, WeInfuse announced a partnership with Trial IQ to enhance AI-driven clinical research for infusion providers, focusing on automating trial processes and improving patient care. Read more
CPC Biotech and Multiply Labs Partner for Cell Therapy Automation
CPC Biotech and Multiply Labs have teamed up to improve cell therapy manufacturing using robotic automation. The collaboration focuses on creating an aseptic connector for robotic use to enhance production efficiency and reduce contamination risks. Read more
Metabolon Introduces AI-Enhanced Metabolomics Kit
Metabolon, Inc. has launched the Metabolon Verus™ profiling kit to make metabolomics more accessible to researchers globally. The kit allows labs to produce standardized metabolomics data and access Metabolon's bioinformatics platform, aiming to improve reproducibility and accessibility in research. Read more
Causaly Launches AI-Driven Scientific Workflows
Causaly has introduced Scientific Workflows, a platform that automates biopharma R&D processes using AI, aiming to improve decision-making and speed up research. Read more
Cortechs.ai and Microsoft Collaborate on AI in Radiology
Cortechs.ai has partnered with Microsoft to integrate AI-powered imaging insights into clinical radiology workflows. The collaboration aims to enhance diagnostic precision and streamline reporting using Microsoft Azure's cloud infrastructure. Read more
Adaptive Innovations Secures $50M for AI Healthcare Expansion
Adaptive Innovations has raised $50 million in Series A funding to enhance its AI platform and grow its clinical workforce, with backing from Felicis and Bain Capital Ventures. Read more
Serif Health Launches AI-Powered Signal Ask
Serif Health has introduced Signal Ask, an AI-powered feature aimed at improving healthcare pricing intelligence. The tool is designed to simplify pricing data navigation for analysts and includes guided Starter Kits and a unified research workflow. Read more
Converge Bio Receives $2.5M Grant for AI in Crop Genomics
Converge Bio has been awarded a $2.5 million grant by the Gates Foundation to enhance its AI platform for crop genomics. The initiative aims to identify genetic variants to improve agricultural traits and food security. Read more
RSC Bay Area Implements Alife Health's AI Tool for IVF
RSC Bay Area is the first U.S. clinic to use Alife Health's FDA-cleared AI tool, Embryo Predict™, for embryo assessment in IVF, aiming to improve patient outcomes. Read more
Pathwork Launches AI Platform for Insurance Brokers
Pathwork has introduced an AI platform to help life insurance brokers access medical data efficiently, enhancing the underwriting process. Read more
Quotient Sciences Begins AI-Designed Drug Study
Quotient Sciences has started a Phase I clinical study for an AI-developed oral drug, approved by the UK's MHRA, to evaluate its safety and pharmacokinetics in healthy volunteers. Read more
CVS Health and Salesforce Expand AI Collaboration
CVS Health and Salesforce have announced an expansion of their collaboration to improve call center experiences using AI agents, aiming to streamline interactions and provide personalized support. Read more
Labcorp and Alliance for Clinical Trials in Oncology Collaborate on AI-Driven Genetic Testing
Labcorp has partnered with the Alliance for Clinical Trials in Oncology to conduct a national clinical trial focused on enhancing genetic testing for colorectal cancer using AI. The trial aims to increase testing among at-risk family members and evaluate the impact of multigene panel testing on newly diagnosed patients. Read more
Nucs AI and AstraZeneca Collaborate on AI for Prostate Cancer
Nucs AI has partnered with AstraZeneca to develop AI-driven models to predict responses to therapeutic radioconjugates in metastatic prostate cancer, aiming to improve precision oncology. Read more
Kythera Labs Launches Wayfinder DataSync
Kythera Labs has introduced Wayfinder DataSync, an AI tool designed to enhance patient data integration and improve strategic decision-making in healthcare organizations. Read more
Rice University and Baylor College of Medicine Launch BCI Clinical Trial
Rice University and Baylor College of Medicine are conducting a clinical trial to develop brain-computer interface technologies aimed at assisting individuals with tetraplegia. This marks Texas's first involvement in the BrainGate consortium's efforts to advance BCI technology. Read more
Sino Biological Aids Tencent AI in Protein Design Study
Sino Biological, Inc. announced its cell-free protein synthesis technology was used in a study by Tencent AI for Life Sciences Lab, published in Nature Communications. The study achieved advancements in AI-designed proteins' activity and stability. Read more
SKIA's AR Surgical System Gets FDA Clearance
South Korean medtech company SKIA has received FDA clearance for its SKIA HEAD augmented reality surgical guidance system, enabling its U.S. commercial launch in partnership with Structure. Read more
Tissue Dynamics and Galmed Discover New Pathway for Cardiac Fibrosis
Tissue Dynamics and Galmed Pharmaceuticals have identified a new metabolic pathway involved in cardiac fibrosis using AI, potentially leading to novel treatments for heart failure. Read more
DeepIntent Partners with Lane4.io for EHR Advertising
On May 28, 2026, DeepIntent announced a partnership with Lane4.io to enhance programmatic access to point-of-care media through improved EHR advertising capabilities. Read more
Lunai Bioworks and BrainStorm Partner for AI Drug Discovery
Lunai Bioworks and BrainStorm Therapeutics have partnered to use AI for discovering new drug targets for neurological diseases, funded by the LouLou Foundation. Read more
Alife Health's AI Embryo Tool Gets FDA Clearance
Alife Health has received FDA clearance for its AI-driven tool, Embryo Predict, which aids in embryo selection for IVF by analyzing images and providing AI scores. Read more
Alaw Therapeutics Advances AI-Enabled Oncology Programs
Alaw Therapeutics has announced the initiation of a Phase 1a/b clinical trial for AL-605 and the nomination of AL-433, marking significant progress in their AI-enabled oncology programs targeting brain tumors. Read more
We hope you enjoyed this article.
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from: Life Sciences
06/03
First Foundation Labs Partners with Microsoft to Advance AI Reasoning for Life Sciences
06/03
Ingenix Raises €13 Million to Expand Biological Reasoning Engine for Drug Development
06/03
Adaptive Innovations Raises $50 Million Series A to Expand AI Healthcare Platform
06/02
American Diabetes Association Invests in UpDoc for AI Chronic Care Platform
06/02
WeInfuse and Trial IQ Partner to Integrate AI Clinical Research Tools for Infusion Providers
Subscribe to Life AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
